{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:26:26Z","timestamp":1792081586897,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Aqueous extracts from leaves of well known species of the Lamiaceae family were examined for their potency to inhibit infection by human immunodeficiency virus type 1 (HIV-1).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Extracts from lemon balm (<jats:italic>Melissa officinalis<\/jats:italic> L.), peppermint (<jats:italic>Mentha<\/jats:italic> \u00d7 <jats:italic>piperita<\/jats:italic> L.), and sage (<jats:italic>Salvia officinalis<\/jats:italic> L.) exhibited a high and concentration-dependent activity against the infection of HIV-1 in T-cell lines, primary macrophages, and in <jats:italic>ex vivo<\/jats:italic> tonsil histocultures with 50% inhibitory concentrations as low as 0.004%. The aqueous Lamiaceae extracts did not or only at very high concentrations interfere with cell viability. Mechanistically, extract exposure of free virions potently and rapidly inhibited infection, while exposure of surface-bound virions or target cells alone had virtually no antiviral effect. In line with this observation, a virion-fusion assay demonstrated that HIV-1 entry was drastically impaired following treatment of particles with Lamiaceae extracts, and the magnitude of this effect at the early stage of infection correlated with the inhibitory potency on HIV-1 replication. Extracts were active against virions carrying diverse envelopes (X4 and R5 HIV-1, vesicular stomatitis virus, ecotropic murine leukemia virus), but not against a non-enveloped adenovirus. Following exposure to Lamiaceae extracts, the stability of virions as well as virion-associated levels of envelope glycoprotein and processed Gag protein were unaffected, while, surprisingly, sucrose-density equilibrium gradient analyses disclosed a marked increase of virion density.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Aqueous extracts from Lamiaceae can drastically and rapidly reduce the infectivity of HIV-1 virions at non-cytotoxic concentrations. An extract-induced enhancement of the virion's density prior to its surface engagement appears to be the most likely mode of action. By harbouring also a strong activity against herpes simplex virus type 2, these extracts may provide a basis for the development of novel virucidal topical microbicides.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-4690-5-27","type":"journal-article","created":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T19:14:35Z","timestamp":1206040475000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density"],"prefix":"10.1186","volume":"5","author":[{"given":"Silvia","family":"Geuenich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Goffinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Venzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Nolkemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Plinkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Reichling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver T","family":"Keppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,20]]},"reference":[{"issue":"10","key":"852_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJMra025195","volume":"350","author":"F Clavel","year":"2004","unstructured":"Clavel F, Hance AJ: HIV drug resistance. N Engl J Med. 2004, 350 (10): 1023-1035. 10.1056\/NEJM2ra025195.","journal-title":"N Engl J Med"},{"issue":"5","key":"852_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nri1848","volume":"6","author":"MM Lederman","year":"2006","unstructured":"Lederman MM, Offord RE, Hartley O: Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol. 2006, 6 (5): 371-382. 10.1038\/nri1848.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"852_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1034\/j.1600-0897.2003.00044.x","volume":"49","author":"MJ Keller","year":"2003","unstructured":"Keller MJ, Klotman ME, Herold BC: Development of topical microbicides for prevention of human immunodeficiency virus and herpes simplex virus. Am J Reprod Immunol. 2003, 49 (5): 279-284. 10.1034\/j.1600-0897.2003.00044.x.","journal-title":"Am J Reprod Immunol"},{"issue":"8","key":"852_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1517\/13543784.11.8.1077","volume":"11","author":"JA Turpin","year":"2002","unstructured":"Turpin JA: Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin Investig Drugs. 2002, 11 (8): 1077-1097. 10.1517\/13543784.11.8.1077.","journal-title":"Expert Opin Investig Drugs"},{"key":"852_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3181\/00379727-117-29600","volume":"117","author":"RA Cohen","year":"1964","unstructured":"Cohen RA, Kucera LS, Herrmann EC: Antiviral Activity of Melissa Officinalis (Lemon Balm) Extract. Proc Soc Exp Biol Med. 1964, 117: 431-434.","journal-title":"Proc Soc Exp Biol Med"},{"key":"852_CR6","first-page":"65","volume":"29","author":"Z Dimitrova","year":"1993","unstructured":"Dimitrova Z, B D, Manolova N, Pancheva S, Ilieva D, Shishkov S: Antiherpes effect of Melissa officinalis L. extracts. Acta Microbiol Bulg. 1993, 29: 65-72.","journal-title":"Acta Microbiol Bulg"},{"key":"852_CR7","first-page":"109","volume":"136","author":"A Mohrig","year":"1996","unstructured":"Mohrig A: Melissenextrakt bei Herpes simplex \u2013 die Alternative zu Nukleosid-Analoga. Dt Apoth Zt. 1996, 136: 109-114.","journal-title":"Dt Apoth Zt"},{"issue":"15","key":"852_CR8","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1055\/s-2006-951719","volume":"72","author":"S Nolkemper","year":"2006","unstructured":"Nolkemper S, Reichling J, Stintzing FC, Carle R, Schnitzler P: Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Planta Med. 2006, 72 (15): 1378-1382. 10.1055\/s-2006-951719.","journal-title":"Planta Med"},{"issue":"1\u20132","key":"852_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65 (1\u20132): 55-63. 10.1016\/0022-1759(83)90303-4.","journal-title":"J Immunol Methods"},{"issue":"4","key":"852_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1074-7613(01)00217-5","volume":"15","author":"DA Eckstein","year":"2001","unstructured":"Eckstein DA, Penn ML, Korin YD, Scripture-Adams DD, Zack JA, Kreisberg JF, Roederer M, Sherman MP, Chin PS, Goldsmith MA: HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity. 2001, 15 (4): 671-682. 10.1016\/S1074-7613(01)00217-5.","journal-title":"Immunity"},{"issue":"10","key":"852_CR11","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1128\/JVI.77.10.5846-5854.2003","volume":"77","author":"A Jekle","year":"2003","unstructured":"Jekle A, Keppler OT, De Clercq E, Schols D, Weinstein M, Goldsmith MA: In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J Virol. 2003, 77 (10): 5846-5854. 10.1128\/JVI.77.10.5846-5854.2003.","journal-title":"J Virol"},{"issue":"11","key":"852_CR12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nbt745","volume":"20","author":"M Cavrois","year":"2002","unstructured":"Cavrois M, De Noronha C, Greene WC: A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol. 2002, 20 (11): 1151-1154. 10.1038\/nbt745.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"852_CR13","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/3293","volume":"4","author":"JM Kilby","year":"1998","unstructured":"Kilby JM, Hopkins S, Venetta TM, DiMassimo B, Cloud GA, Lee JY, Alldredge L, Hunter E, Lambert D, Bolognesi D, Matthews T, Johnson MR, Nowak MA, Shaw GM, Saag MS: Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med. 1998, 4 (11): 1302-1307. 10.1038\/3293.","journal-title":"Nat Med"},{"issue":"14","key":"852_CR14","doi-asserted-by":"publisher","first-page":"7582","DOI":"10.1128\/JVI.78.14.7582-7589.2004","volume":"78","author":"ML Heil","year":"2004","unstructured":"Heil ML, Decker JM, Sfakianos JN, Shaw GM, Hunter E, Derdeyn CA: Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site. J Virol. 2004, 78 (14): 7582-7589. 10.1128\/JVI.78.14.7582-7589.2004.","journal-title":"J Virol"},{"issue":"2","key":"852_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.virol.2004.12.035","volume":"333","author":"T Neumann","year":"2005","unstructured":"Neumann T, Hagmann I, Lohrengel S, Heil ML, Derdeyn CA, Krausslich HG, Dittmar MT: T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells. Virology. 2005, 333 (2): 251-262. 10.1016\/j.virol.2004.12.035.","journal-title":"Virology"},{"issue":"8","key":"852_CR16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cub.2005.02.058","volume":"15","author":"N Michel","year":"2005","unstructured":"Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT: The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol. 2005, 15 (8): 714-723. 10.1016\/j.cub.2005.02.058.","journal-title":"Curr Biol"},{"issue":"22","key":"852_CR17","doi-asserted-by":"publisher","first-page":"11141","DOI":"10.1128\/JVI.01556-06","volume":"80","author":"S Venzke","year":"2006","unstructured":"Venzke S, Michel N, Allespach I, Fackler OT, Keppler OT: Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection. J Virol. 2006, 80 (22): 11141-11152. 10.1128\/JVI.01556-06.","journal-title":"J Virol"},{"key":"852_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1742-4690-4-53","volume":"4","author":"C Goffinet","year":"2007","unstructured":"Goffinet C, Michel N, Allespach I, Tervo HM, Hermann V, Krausslich HG, Greene WC, Keppler OT: Primary T-cells from human CD4\/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression. Retrovirology. 2007, 4: 53-10.1186\/1742-4690-4-53.","journal-title":"Retrovirology"},{"issue":"12","key":"852_CR19","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1128\/jvi.70.12.8701-8709.1996","volume":"70","author":"J Goncalves","year":"1996","unstructured":"Goncalves J, Korin Y, Zack J, Gabuzda D: Role of Vif in human immunodeficiency virus type 1 reverse transcription. J Virol. 1996, 70 (12): 8701-8709.","journal-title":"J Virol"},{"issue":"3","key":"852_CR20","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1128\/jvi.69.3.1778-1784.1995","volume":"69","author":"M Ottmann","year":"1995","unstructured":"Ottmann M, Gabus C, Darlix JL: The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J Virol. 1995, 69 (3): 1778-1784.","journal-title":"J Virol"},{"issue":"8","key":"852_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrmicro1707","volume":"5","author":"J Balzarini","year":"2007","unstructured":"Balzarini J: Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol. 2007, 5 (8): 583-597. 10.1038\/nrmicro1707.","journal-title":"Nat Rev Microbiol"},{"issue":"19","key":"852_CR22","doi-asserted-by":"publisher","first-page":"10556","DOI":"10.1128\/JVI.78.19.10556-10565.2004","volume":"78","author":"S Campbell","year":"2004","unstructured":"Campbell S, Gaus K, Bittman R, Jessup W, Crowe S, Mak J: The raft-promoting property of virion-associated cholesterol, but not the presence of virion-associated Brij 98 rafts, is a determinant of human immunodeficiency virus type 1 infectivity. J Virol. 2004, 78 (19): 10556-10565. 10.1128\/JVI.78.19.10556-10565.2004.","journal-title":"J Virol"},{"issue":"17","key":"852_CR23","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/00002030-200211220-00004","volume":"16","author":"SM Campbell","year":"2002","unstructured":"Campbell SM, Crowe SM, Mak J: Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. Aids. 2002, 16 (17): 2253-2261. 10.1097\/00002030-200211220-00004.","journal-title":"Aids"},{"issue":"6442","key":"852_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/365113a0","volume":"365","author":"S Jiang","year":"1993","unstructured":"Jiang S, Lin K, Strick N, Neurath AR: HIV-1 inhibition by a peptide. Nature. 1993, 365 (6442): 113-10.1038\/365113a0.","journal-title":"Nature"},{"issue":"21","key":"852_CR25","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","volume":"91","author":"CT Wild","year":"1994","unstructured":"Wild CT, Shugars DC, Greenwell TK, McDanal CB, Matthews TJ: Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci USA. 1994, 91 (21): 9770-9774. 10.1073\/pnas.91.21.9770.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"852_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2007.02.042","volume":"129","author":"J M\u00fcnch","year":"2007","unstructured":"M\u00fcnch J, Standker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pohlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F: Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell. 2007, 129 (2): 263-275. 10.1016\/j.cell.2007.02.042.","journal-title":"Cell"},{"issue":"14","key":"852_CR27","doi-asserted-by":"publisher","first-page":"7636","DOI":"10.1128\/JVI.02851-06","volume":"81","author":"RP Madan","year":"2007","unstructured":"Madan RP, Mesquita PM, Cheshenko N, Jing B, Shende V, Guzman E, Heald T, Keller MJ, Regen SL, Shattock RJ, Herold BC: Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections. J Virol. 2007, 81 (14): 7636-7646. 10.1128\/JVI.02851-06.","journal-title":"J Virol"},{"issue":"17","key":"852_CR28","doi-asserted-by":"publisher","first-page":"8063","DOI":"10.1128\/JVI.75.17.8063-8073.2001","volume":"75","author":"OT Keppler","year":"2001","unstructured":"Keppler OT, Yonemoto W, Welte FJ, Patton KS, Iacovides D, Atchison RE, Ngo T, Hirschberg DL, Speck RF, Goldsmith MA: Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J Virol. 2001, 75 (17): 8063-8073. 10.1128\/JVI.75.17.8063-8073.2001.","journal-title":"J Virol"},{"issue":"3","key":"852_CR29","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1073\/pnas.0607414104","volume":"104","author":"C Goffinet","year":"2007","unstructured":"Goffinet C, Allespach I, Keppler OT: HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription. Proc Natl Acad Sci USA. 2007, 104 (3): 1015-1020. 10.1073\/pnas.0607414104.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"852_CR30","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1128\/JVI.79.3.1655-1665.2005","volume":"79","author":"OT Keppler","year":"2005","unstructured":"Keppler OT, Allespach I, Schuller L, Fenard D, Greene WC, Fackler OT: Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J Virol. 2005, 79 (3): 1655-1665. 10.1128\/JVI.79.3.1655-1665.2005.","journal-title":"J Virol"},{"issue":"6","key":"852_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1084\/jem.20011549","volume":"195","author":"OT Keppler","year":"2002","unstructured":"Keppler OT, Welte FJ, Ngo TA, Chin PS, Patton KS, Tsou CL, Abbey NW, Sharkey ME, Grant RM, You Y, Scarborough JD, Ellmeier W, Littman DR, Stevenson M, Charo IF, Herndier BG, Speck RF, Goldsmith MA: Progress toward a human CD4\/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J Exp Med. 2002, 195 (6): 719-736. 10.1084\/jem.20011549.","journal-title":"J Exp Med"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4690-5-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:14:03Z","timestamp":1630458843000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/1742-4690-5-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1186\/1742-4690-5-27","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,20]]},"assertion":[{"value":"19 December 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}